comparemela.com

Latest Breaking News On - Peter greenleaf - Page 1 : comparemela.com

ILJIN SNT Co., Ltd. Calls for Board Restructure at Aurinia Pharmaceuticals

/PRNewswire/ Fellow Aurinia Shareholders, ILJIN SNT Co., Ltd. and its affiliates (collectively, "ILJIN") is a long-term holder of more than 5% of Aurinia.

Seoul
Soult-ukpyolsi
South-korea
Peter-greenleaf
Yoonwha-lee
Daniel-billen
Robert-foster
Given-the-company
Aurinia-pharmaceuticals-inc
Co-ltd
Aurinia-shareholders
Aurinia-pharmaceuticals

On behalf of Lucien Selce: Aurinia Pharmaceuticals Shareholder Urges Board of Directors to Take Action to Enhance Shareholder Value

On behalf of Lucien Selce: Aurinia Pharmaceuticals Shareholder Urges Board of Directors to Take Action to Enhance Shareholder Value
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Robert-foster
Daniel-billen
Peter-greenleaf
Lucien-selce
Zwei-rohstoff-chancen
Jeffrey-bailey
Karen-smith
Experte-carsten-stork
Company-current-strategy
Nasdaq
Co-ltd

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2024 Earnings Call Transcript

Aurinia Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.07464, expectations were $-0.17.

Japan
Canada
Florida
United-states
Switzerland
Canadian
Japanese
Swiss
Farzin-haque
Greg-keenan
Stacy-ku
Andrea-christopher

Aurinia Pharmaceuticals Reports First Quarter 2024 Financial and Operational Results

Achieved $50.3 million in total net revenue and $48.1 million in net product revenue for the first quarter of 2024, representing year over year growth of approximately 46% and 40% respectively, and.

Canada
Maryland
United-states
Rockville
Canadian
Peter-greenleaf
Clinical-program
Nasdaq
Aurinia-pharmaceuticals-inc
Company-annual-report-on-form
Company-quarterly-report-on-form
Share-repurchase-program

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.